Elite Diagnostic Limited (JMSE:ELITE)

Jamaica · Delayed Price · Currency is JMD

1.790

-0.010 (-0.56%)

At close: Oct 16, 2026

Market Cap	632.59M +19.3%
Revenue (ttm)	867.29M +1.6%
Net Income	27.60M -13.8%
EPS	0.08 -13.8%
Shares Out	353.40M
PE Ratio	22.92
Forward PE	n/a
Dividend	0.01 (0.56%)
Ex-Dividend Date	Sep 19, 2025

Volume	91
Open	n/a
Previous Close	1.800
Day's Range	1.790 - 1.790
52-Week Range	1.020 - 2.000
Beta	0.06
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Elite Diagnostic

Elite Diagnostic Limited engages in the provision of diagnostic imaging services in Jamaica. It offers medical imaging services, including CT scan, MRI, X-Ray, ultrasound, and fluoroscopy services. The company also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica. [Read more]

Industry Medical Laboratories

Founded 2012

Country Jamaica

Stock Exchange Jamaica Stock Exchange

Ticker Symbol ELITE

Full Company Profile

Financial Performance

In fiscal year 2026, Elite Diagnostic's revenue was 867.29 million, an increase of 1.58% compared to the previous year's 853.82 million. Earnings were 27.60 million, a decrease of -13.82%.

Financial Statements